GR: Difference between revisions

From REBody
Jump to navigation Jump to search
Update inference §1 (diagram)
Update inference §3 (diagram)
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{#inference:id=1|to=Dexras1|tag=induces expression of}}<ref>{{cite web|url=https://www.nature.com/articles/srep28648|title=Dexras1 links glucocorticoids to insulin-like growth factor-1 signaling in adipogenesis|website=Nature|quote=Previously, we showed that small G protein Dexras1 is expressed by glucocorticoids and leads to adipocyte differentiation}}</ref>
{{#inference:id=1|to=Dexras1|tag=induces expression of}}<ref>{{cite web|url=https://www.nature.com/articles/srep28648|title=Dexras1 links glucocorticoids to insulin-like growth factor-1 signaling in adipogenesis|website=Nature|author=Hyo Jung Kim, et al.|quote=Previously, we showed that small G protein Dexras1 is expressed by glucocorticoids and leads to adipocyte differentiation}}</ref>


== References ==
== References ==
<references />
<references />
{{#inference:id=3|to=CDK|tag=displaces ERα from|context=specifically CCND1/CDK2/CDK6, via FOXA1-primed chromatin sites}}<ref>{{cite web
|title=Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.
|author=Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD
|date=2019 Jul 24
|publisher=Breast cancer research : BCR
|url=https://pubmed.ncbi.nlm.nih.gov/31340854/
|pmid=31340854
|quote=
}}</ref>


[[Category:Receptor]]
[[Category:Receptor]]

Latest revision as of 22:57, 20 July 2026

induces expression of Dexras1[1]

References

  1. Hyo Jung Kim, et al.."Dexras1 links glucocorticoids to insulin-like growth factor-1 signaling in adipogenesis".
    Previously, we showed that small G protein Dexras1 is expressed by glucocorticoids and leads to adipocyte differentiation

displaces ERα from CDK (specifically CCND1/CDK2/CDK6, via FOXA1-primed chromatin sites)[1]

  1. Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD."Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.".